Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro

Oncology Reports

Volumn 20, Issue 2, 2008, Pages 413-419

  Said, Harun M ^a   Polat, Buelent ^a   Staab, Adrian ^a   Hagemann, Carsten ^a   Stein, Susanne ^b   Flentje, Michael ^a   Theobald, Mathias ^b   Katzer, Astrid ^a   Vordermark, Dirk ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Carbonic anhydrase IX; Hypoxia; Hypoxia inducible factor 1 ; N Myc down regulated gene 1; Oxygen; Radiotherapy; Reoxygenation; Tumor hypoxia

Indexed keywords

CARBONATE DEHYDRATASE IX; HYPOXIA INDUCIBLE FACTOR 1; MYC PROTEIN; N MYC DOWN REGULATED GENE 1;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL HYPOXIA; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYPOXIA; HYPOXIC CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REOXYGENATION;

ANOXIA; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; BRAIN NEOPLASMS; CARBONIC ANHYDRASES; CELL CYCLE PROTEINS; CELL NUCLEUS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; OXYGEN; RESPONSE ELEMENTS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 48749104364     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or_00000023     Document Type: Article

References (48)

1. Elstner A, Holtkamp N and von Deimling A: Involvement of HIF-1 in desferrioxamine-induced invasion of glioblastoma cells. Clin Exp Metastasis 24: 57-66, 2007.
2. Hodges TW, Hossain CF, Kim YP, Zhou YD and Nagle DG: Molecular-targeted antitumor agents: the Saururus cernuus dineolignans manassantin B and 4-O-demethylmanassantin B are potent inhibitors of hypoxia-activated HIF-1. J Nat Prod 67: 767-771, 2004.
3. Turcotte ML, Parliament M, Franko A and Allalunis-Turner J: Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells. Br J Cancer 86: 619-624, 2002.
4. Secomb TW, Hsu R, Braun RD, et al: Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels. Adv Exp Med Biol 454: 629-634, 1998.
5. Yoshida D, Kim K, Noha M and Teramoto A: Hypoxia inducible factor 1-alpha regulates of platelet derived growth factor-B in human glioblastoma cells. J Neurooncol 76: 13-21, 2006.
6. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
7. Brown JM and Wilson WR: Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4: 437-447, 2004.
8. Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ and van der Wall E: Levels of hypoxia-inducible factor-1α during breast carcinogenesis. J Natl Cancer Inst 93: 309-314, 2001.
9. Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ and van der Wall E: Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97: 1573-1581, 2003.
10. Vordermark D, Kaffer A, Riedl S, Katzer A and Flentje M: Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells. Int J Radiat Oncol Biol Phys 61: 1197-1207, 2005.
11. Haapasalo JA, Nordfors KM, Hilvo M, Rantala IJ, Soini Y, Parkkila AK, Pastoreková S, Pastorek J, Parkkila SM and Haapasalo HK: Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clin Cancer Res 12: 473-477, 2006.
12. Saarnio J, Parkkila S, Parkkila AK, Haukipuro K, Pastoreková S, Pastorek J, Kairaluoma MI and Karttunen TJ: Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol 153: 279-285, 1998.
13. Said HM, Staab A, Hagemann C, et al: Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines. J Neurooncol 81: 27-38, 2007.
14. Qu X, Zhai Y, Wei H, et al: Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 229: 35-44, 2002.
15. Bandyopadhyay S, Pai SK, Gross SC, et al: The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63: 1731-1736, 2003.
16. Piquemal D, Joulia D and Commes T: Transforming growth factor-β1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids. Biochim Biophys Acta 1450: 364-373, 1999.
17. van Belzen N, Dinjens WN, Diesveld MP, et al: A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77: 85-92, 1997.
18. Angst E, Sibold S, Tiffon C, et al: Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. Br J Cancer 95: 307-313, 2006.
19. Greijer AE, van der Groep P, Kemming D, et al: Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206: 291-304, 2005.
20. Salnikow K, Davidson T, Zhang Q, et al: The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis. Cancer Res 63: 3524-3530, 2003.
21. Cangul H: Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 5: 27, 2004.
22. Han YH, Xia L, Song LP, et al: Comparative proteomic analysis of hypoxia-treated and untreated human leukemic U937 cells. Proteomics 6: 3262-3274, 2007.
23. Zhang P, Tchou-Wong KM and Costa M: Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res 67: 9125-9133, 2007.
24. Ellen T, Ke Q, Zhang P and Costa M: NDRG1, a growth and cancer related gene: Regulation of gene expression and function in normal and disease states. Carcinogenesis (In press).
25. Brown JM and Le QT: Tumor hypoxia is important in radiotherapy, but how should we measure it? Int J Radiat Oncol Biol Phys 54: 1299-1301, 2002.
26. Akslen LA, Andersen KJ and Bjerkvig R: Characteristics of human and rat glioma cells grown in a defined medium, Anticancer Res 8: 797-803, 1988.
27. Said HM, Hagemann C, Staab A, Stojic J, Kühnel S, Vince GH, Flentje M, Roosen K and Vordermark D: Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Radiother Oncol 83: 398-405, 2007.
28. Said HM, Hagemann C, Stojic J, et al: GAPDH is not regulated in human glioblastoma under hypoxic conditions. BMC Mol Biol 8: 55, 2007.
29. Coleman CN, Mitchell JB and Camphausen K: Tumor hypoxia: chicken, egg, or a piece of the farm? J Clin Oncol 20: 610-615, 2002.
30. Gao W, Ferguson G, Connell P, Walshe T, Murphy R, Birney YA, O'Brien C and Cahill PA: High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1alpha-dependent pathway. J Mol Cell Cardiol 42: 609-619, 2007.
31. Vordermark D, Menke DR and Brown JM: Similar radiation sensitivities of acutely and chronically hypoxic cells in HT 1080 fibrosarcoma xenografts. Radiat Res 159: 94-101, 2003.
32. Dooley S, Said HM, Gressner AM, et al: Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J Biol Chem 281: 1784-1795, 2006.
33. Said HM, Katzer A, Flentje M, et al: Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells. Radiother Oncol 76: 200-205, 2005.
34. Collingridge DR, Piepmaier JM, Rockwell S and Knisely JP: Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 53: 127-131, 1999.
35. Evans SM, Judy KD, Dunphy I, Jenkins WT, Hwang WT, Nelson PT, Lustig RA, Jenkins K, Magarelli DP, Hahn SM, Collins RA, Grady MS and Koch CJ: Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 10: 8177-8184, 2004.
36. Koukourakis MI, Giatromanolaki A, Sivridis E, et al: Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin Cancer Res 7: 3399-3403, 2001.
37. Rich JN: Cancer stem cells in radiation resistance. Cancer Res 67: 8980-8984, 2007.
38. DeHaan C, Habibi-Nazhad B, Yan E, Salloum N, Parliament M and Allalunis-Turner J: Mutation in mitochondrial complex I ND6 subunit is associated with defective response to hypoxia in human glioma cells. Mol Cancer 3: 19, 2004.
39. Ragel BT, Couldwell WT, Gillespie DL and Jensen RL: Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurg Rev 30: 181-187, 2007.
40. McMillan KM, Rogers BP, Field AS, Laird AR, Fine JP and Meyerand ME: Physiologic characterisation of glioblastoma multiforme using MRI-based hypoxia mapping, chemical shift imaging, perfusion and diffusion maps. J Clin Neurosci 13: 811-817, 2006.
41. Kaluz S, Kaluzova M and Stanbridge EJ: Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer. Cancer Res 63: 917-922, 2003.
42. Rafajova M, Zatovicova M, Kettmann R, Pastorek J and Pastoreková S: Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells. Int J Oncol 24: 995-1004, 2004.
43. Olive PL, Vikse C and Trotter MJ: Measurement of oxygen diffusion distance. Measurement of oxygen diffusion distance in tumor cubes using a fluorescent hypoxia probe. Int J Radiat Oncol Biol Phys 22: 397-402, 1992.
44. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275, 1999.
45. Pastoreková S and Pastorek J: In: Carbonic Anhydrase. Its Inhibitors and Activators. Supuran CT, Scozzafava A and Conway J (eds). CRC, Boca Raton, pp255-281, 2004.
46. Semenza GL: Hypoxia and cancer. Cancer Metastasis Rev 26: 223-224, 2007.
47. Brahimi-Horn MC and Pouyssegur J: Oxygen, a source of life and stress. FEBS Lett 581: 3582-3591, 2007.
48. Yunokawa M, Tanimoto K, Nakamura H, Nagai N, Kudo Y, Kawamoto T, Kato Y, Hiyama E, Hiyama K and Nishiyama M: Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas. Oncol Rep 17: 871-878, 2007.